Center for Scientific Review; Notice of Closed Meetings, 52691-52693 [2021-20519]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 181 / Wednesday, September 22, 2021 / Notices
demonstrated commitment to the SMBP
Program’s overarching goals and
objectives:
• Working to increase behaviors
women can take to improve their heart
health;
• Increasing access to resources and
information regarding hypertension,
cardiovascular disease, health risks
associated with high blood pressure,
and factors that increase the risk of high
blood pressure;
• Increasing knowledge and
utilization of SMBP activities (also
referred to as ‘‘self-monitoring’’);
• Increasing understanding of blood
pressure needs and understanding of
blood pressure numbers;
• Increasing number of women
collaborating with healthcare providers
with a focus on self-monitoring blood
pressure control, with special
consideration to adapt or modify
activities to meet the needs of diverse,
minority, underserved, and hard to
reach populations;
• Expanding efforts to reach those
disproportionately affected by high
blood pressure, including Black or
African American women, Latina
women, Asian/Pacific Islander women,
American Indian/Alaska Native women,
women of reproductive age, women in
rural communities, and women across
the lifespan, to include those negatively
affected by comorbidities and social
determinants of health;
• Developing partnerships to promote
SMBP across a variety of sectors,
including business, community,
academic, education, faith based,
government, health care, media, public
health, and technology;
• Partnering with national, state,
tribal, or local volunteer organizations
to provide education, training, or
programs regarding health promotion,
disease prevention, hypertension,
SMBP, health disparities, health equity,
and well-being; and/or
• Including information in their
public facing materials about programs
for hypertension, addressing SMBP,
eliminating disparities, achieving health
equity, and/or promoting well-being in
communities.
Funds: Neither HHS nor OWH will
provide funds to support SMBP Program
partners. Applicants, OWH, and SMBP
Program partners will not be expected to
contribute funds.
Application: Organizations may apply
to be an SMBP Program partner.
Organizations should submit a letter of
interest acknowledging their support of
the SMBP Program’s overarching goals.
Organizations interested in being SMBP
Program partners shall identify in their
letters of interest those activities from
VerDate Sep<11>2014
16:44 Sep 21, 2021
Jkt 253001
the list noted above that demonstrate
commitment to the SMBP Program’s
overarching goals and objectives and
indicate how they address or support
those goals.
DATES: Letters of interest to become an
SMBP Program partner should be
submitted to OWHBPPartner@hhs.gov.
Letters of interest will be accepted
starting October 1, 2021 and will be
reviewed periodically. OWH will
conduct informational webinars for
interested applicants. Interested
organizations may use the following
links to register for the informational
webinars:
• September 24, 2021, at 1 p.m. Eastern
Time (ET)
• September 27, 2021, at 1 p.m. Eastern
Time (ET)
Letters of interest can be
submitted via email to OWHBPPartner@
hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Keiva Nelson, Office on Women’s
Health, Office of the Assistant Secretary
for Health, U.S. Department of Health
and Human Services; 200 Independence
Avenue SW, 712E, Washington, DC
20201; Email: OWHBPPartner@hhs.gov.
SUPPLEMENTARY INFORMATION:
Background: The HHS Office on
Women’s Health (OWH) is charged with
providing expert advice and
consultation to the Secretary concerning
scientific, legal, ethical, and policy
issues related to women’s health. OWH
establishes short-range and long-range
goals within the Department and
coordinates on activities within the
Department that relate to disease
prevention, health promotion, service
delivery, research, and public and
health care professional education, for
issues of particular concern to women
throughout their lifespan. OWH
monitors the Department’s activities
regarding women’s health and identifies
needs regarding the coordination of
activities. OWH is also responsible for
facilitating the exchange of information
through the National Women’s Health
Information Center. Additionally, OWH
coordinates efforts to promote women’s
health programs and policies with the
private sector.
Requirements of Interested
Organizations: OWH invites
organizations to submit a letter of
interest to become a SMBP Program
partner.
Organizations selected by OWH to be
SMBP Program partners will sign a
letter of understanding (LOU) with
OWH outlining the terms and
parameters of their support for the
SMBP Program. Selection as an SMBP
ADDRESSES:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
52691
Program partner does not imply any
federal endorsement of the collaborating
organization’s general policies,
activities, or products.
Eligibility for Interested
Organizations: To be eligible to become
an SMBP Program partner, an
organization shall: (1) Have a
demonstrated interest in, understanding
of, and experience with working to
promote access to resources and
information regarding hypertension,
cardiovascular disease, factors that
increase the risk of high blood pressure,
health risks associated with high blood
pressure, prevention strategies and selfmeasured blood pressure, health
disparities, and health equity or (2) have
an organizational or corporate mission
that is aligned with the SMBP Program’s
goals; and (3) agree to sign a LOU with
OWH, which will set forth the details of
how the organization is supporting the
goals of the SMBP Program.
Letter of Interest Requirements: Each
SMBP Program letter of interest shall
contain: (1) Organization name,
location, website, and submitter’s
contact information; (2) a brief
description of the organization’s
mission and/or values; and (3) a
description of how the organization
supports or plans to support the SMBP
Program goals.
Submission of a letter of interest does
not guarantee acceptance as a SMBP
Program partner.
Authority: 42 U.S.C. 237a and 42
U.S.C. 300u–2(a).
Dated: September 14, 2021.
Dorothy A. Fink,
Deputy Assistant Secretary for Women’s
Health.
[FR Doc. 2021–20456 Filed 9–21–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
E:\FR\FM\22SEN1.SGM
22SEN1
52692
Federal Register / Vol. 86, No. 181 / Wednesday, September 22, 2021 / Notices
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–19–
264: Imaging, Biomarkers and Digital
Pathomics for the Early Detection of
Premetastatic Aggressive Cancer.
Date: October 20, 2021.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Eleni Apostolos Liapi.
Scientific Review Officer. Center for
Scientific Review. National Institutes of
Health. 6701 Rockledge Drive. Bethesda, MD
20817. 301–867–5309. eleni.liapi@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR panel:
International Research Ethics Education and
Curriculum Development and Bioethics
Research Training.
Date: October 22, 2021.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 237–
9838, bhagavas@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Clinical Oncology Study Section.
Date: October 25–26, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health.
Rockledge II. 6701 Rockledge Drive.
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Malaya Chatterjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–806–
2515, chatterm@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Gene and Drug Delivery Systems
Study Section.
Date: October 25–26, 2021.
Time: 9:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Jain Krotz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (240) 672–8670,
jain.krotz@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Shared
Instrumentation: Interdisciplinary Molecular
Sciences and Technologies (S10).
Date: October 25–26, 2021.
VerDate Sep<11>2014
16:44 Sep 21, 2021
Jkt 253001
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alexander Gubin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046B,
MSC 7892, Bethesda, MD 20892, 301–408–
9655, gubina@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Clinical Management in General Care
Settings Study Section.
Date: October 25–26, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lauren Fordyce, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3214,
Bethesda, MD 20892, (301) 435–6998,
fordycelm@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Academic Industrial Partnerships for
Translation of Medical Technologies.
Date: October 25–26, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, (301) 237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Skeletal Biology Development and Disease
Study Section.
Date: October 25–27, 2021.
Time: 10:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aruna K. Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, (301) 435–
6809, beheraak@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Biology and
Development of the Eye Study Section.
Date: October 25–26, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas Beres, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7840, Bethesda, MD 20892, 301–435–
1175, berestm@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RM–21–012:
Pilot Projects Investigating Understudied GProtein Coupled Receptors, Ion Channels,
and Protein Kinases.
Date: October 25–26, 2021.
Time: 10:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Pathophysiology of Obesity and Metabolic
Disease Study Section.
Date: October 26–27, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Raul Rojas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6185,
Bethesda, MD 20892, (301) 451–6319, rojasr@
mail.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Molecular Oncogenesis Study Section.
Date: October 26–27, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II .6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific
Review Officer, Center for Scientific Review,
6701 Rockledge Drive, Bethesda, MD 20892,
301–827–5902, caojn@csr.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Instrumentation and Systems
Development Study Section.
Date: October 26–27, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II ,6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kee Forbes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7806, Bethesda, MD 20892, 301–272–
4865, pyonkh2@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
Host Interactions with Bacterial Pathogens
Study Section.
E:\FR\FM\22SEN1.SGM
22SEN1
Federal Register / Vol. 86, No. 181 / Wednesday, September 22, 2021 / Notices
Date: October 26–27, 2021.
Time: 9:45 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Fouad A. El-Zaatari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7808, Bethesda, MD 20892, (301) 435–
1149, elzaataf@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Community Influences on Health Behavior
Study Section.
Date: October 26–27, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pia Kristiina Peltola, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892 (301) 594–9295,
pia.peltola@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 17, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20519 Filed 9–21–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Aging and
Technology.
Date: October 22, 2021.
VerDate Sep<11>2014
16:44 Sep 21, 2021
Jkt 253001
Time: 11:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Kimberly Firth, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, Gateway Building, 7201
Wisconsin Avenue, Suite 2W200, Bethesda,
MD 20892, (301) 402–7702 firthkm@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: September 17, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20520 Filed 9–21–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Hearing
and Balance Fellowship Review.
Date: October 7–8, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Virtual Meeting).
Contact Person: Shiguang Yang, DVM,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Room 8349, Bethesda, MD
20892, 301–496–8683, yangshi@
nidcd.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
52693
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Chemical
Senses Fellowship Review.
Date: October 12, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Shiguang Yang, DVM,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Room 8349, Bethesda, MD
20892, 301–496–8683, yangshi@
nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Voice,
Speech and Language Fellowship Review
Date: October 26, 2021.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Eliane Lazar-Wesley,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room
8339, MSC 9670, Bethesda, MD 20892–8401,
301–496–8683 el6r@nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel Clinical
Trial Review.
Date: October 27, 2021.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Katherine Shim, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, NIH/NIDCD, 6001
Executive Blvd., Room 8351, Bethesda, MD
20892, 301–496–8683 katherine.shim@
nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel, NIDCD
R21/R33 Hearing Health Care Review.
Date: November 5, 2021.
Time: 9:00 a.m. to 11:30 a.m.,
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Katherine Shim, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, NIH/NIDCD 6001
Executive Blvd., Room 8351, Bethesda, MD
20892, 301–496–8683, katherine.shim@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
E:\FR\FM\22SEN1.SGM
22SEN1
]]>Agencies
[Federal Register Volume 86, Number 181 (Wednesday, September 22, 2021)]
[Notices]
[Pages 52691-52693]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20519]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant
[[Page 52692]]
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the
Early Detection of Premetastatic Aggressive Cancer.
Date: October 20, 2021.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Eleni Apostolos Liapi. Scientific Review
Officer. Center for Scientific Review. National Institutes of
Health. 6701 Rockledge Drive. Bethesda, MD 20817. 301-867-5309.
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR panel: International Research Ethics Education and
Curriculum Development and Bioethics Research Training.
Date: October 22, 2021.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Seetha Bhagavan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 237-9838, [email protected].
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Clinical Oncology Study Section.
Date: October 25-26, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health. Rockledge II. 6701
Rockledge Drive. Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Malaya Chatterjee, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD
20892, 301-806-2515, [email protected].
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Gene and Drug Delivery Systems Study
Section.
Date: October 25-26, 2021.
Time: 9:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive,Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jain Krotz, Ph.D., Scientific Review Officer,
Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD
20892, (240) 672-8670, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Shared Instrumentation: Interdisciplinary Molecular Sciences
and Technologies (S10).
Date: October 25-26, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alexander Gubin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046B, MSC 7892, Bethesda, MD
20892, 301-408-9655, [email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Clinical Management in General Care
Settings Study Section.
Date: October 25-26, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lauren Fordyce, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3214, Bethesda, MD 20892, (301)
435-6998, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Academic Industrial Partnerships for Translation
of Medical Technologies.
Date: October 25-26, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, (301) 237-
9870, [email protected].
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group; Skeletal Biology Development and Disease
Study Section.
Date: October 25-27, 2021.
Time: 10:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aruna K. Behera, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211, MSC 7814, Bethesda, MD
20892, (301) 435-6809, [email protected].
Name of Committee: Cell Biology Integrated Review Group; Biology
and Development of the Eye Study Section.
Date: October 25-26, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas Beres, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5148, MSC 7840, Bethesda, MD 20892, 301-435-
1175, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RM-21-012: Pilot Projects Investigating Understudied G-
Protein Coupled Receptors, Ion Channels, and Protein Kinases.
Date: October 25-26, 2021.
Time: 10:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301-435-1180, [email protected].
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Pathophysiology of
Obesity and Metabolic Disease Study Section.
Date: October 26-27, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Raul Rojas, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6185, Bethesda, MD 20892, (301) 451-6319,
[email protected].
Name of Committee: Oncology 1--Basic Translational Integrated
Review Group; Molecular Oncogenesis Study Section.
Date: October 26-27, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II .6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific Review Officer, Center
for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892,
301-827-5902, [email protected].
Name of Committee: Bioengineering Sciences & Technologies
Integrated Review Group; Instrumentation and Systems Development
Study Section.
Date: October 26-27, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II ,6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kee Forbes, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5148, MSC 7806, Bethesda, MD 20892, 301-272-
4865, [email protected].
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group; Host Interactions with Bacterial Pathogens
Study Section.
[[Page 52693]]
Date: October 26-27, 2021.
Time: 9:45 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Fouad A. El-Zaatari, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186, MSC 7808, Bethesda, MD
20892, (301) 435-1149, [email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Community Influences on Health Behavior
Study Section.
Date: October 26-27, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pia Kristiina Peltola, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892 (301) 594-9295, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 17, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-20519 Filed 9-21-21; 8:45 am]
BILLING CODE 4140-01-P
